However, as groundbreaking as these therapies are, they also pose unique challenges for the drug development process, particularly regarding quality assurance (QA). The role of QA is more critical ...

The pharmaceutical industry has long been reliant on rigorous research and development processes to bring life-saving drugs to market ... delays in the development process to the tune of months ...

Integrating genomics and AI is key to increasing the probability of success and accelerating the delivery of treatments to ...

Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.

In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) ...

The average drug now costs more ... very exciting time in drug development,” he adds. “The utilization of AI and big data is revolutionizing our drug-discovery process. What once required ...

Schrodinger (SDGR) and Recursion Pharmaceuticals (RXRX), which both specialize in using AI to hasten drug discovery, are jumping 17% and 11%, respectively. iCAD (ICAD), whose products harness AI ...

On January 6, 2025, the FDA released draft guidance on using artificial intelligence (AI) in regulatory decision-making for ...

"This breakthrough enables the development of better precision ... methods to further refine and accelerate the peptide-drug matching process. Their next steps include verifying the approach's ...